MARKET

SESN

Sesen Bio, Inc.
SESN
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-4.6308
22.32
4.166
661,349,656.50
CARISMA THERAPEUTICS INC <CARM.O>: BAIRD CUTS TO NEUTRAL RATING; CUTS TARGET PRICE TO $1 FROM $10
Reuters · 12/12 06:13
CARISMA THERAPEUTICS INC <CARM.O>: BTIG CUTS TO NEUTRAL FROM BUY
Reuters · 12/10 08:31
CARISMA THERAPEUTICS INC - CHIEF FINANCIAL OFFICER, RICHARD MORRIS WILL LEAVE COMPANY EFFECTIVE DEC 31
Reuters · 12/09 13:30
CARISMA THERAPEUTICS, INC. <CARM.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $5 FROM $8
Reuters · 11/25 11:12
U.S. RESEARCH ROUNDUP-Domino's Pizza, Elastic NV, Snowflake
Reuters · 11/25 07:05
CARISMA UNVEILS PROMISING PRE-CLINICAL DATA ON ANTI-GPC3 IN VIVO CAR-M THERAPY FOR HEPATOCELLULAR CARCINOMA
Reuters · 11/08 12:30
CARISMA -ANTI-GPC3 IN VIVO CAR-M THERAPY WELL TOLERATED IN MOUSE MODELS, HIGHLIGHTING ITS POTENTIAL AS AN OFF--SHELF TREATMENT FOR GPC3+ SOLID TUMORS
Reuters · 11/08 12:30
Carisma Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary
Reuters · 11/07 15:10
More

Webull offers Sesen Bio, Inc. stock information, including NASDAQ: SESN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SESN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SESN stock methods without spending real money on the virtual paper trading platform.